Flourish™ Pediatric Esophageal Atresia
Completed
Conditions studied: Esophageal Atresia, Digestive System Abnormalities, Esophageal Disorders Congenital
In brief
This study is continued evaluation of the safety and probable benefit of the Flourish Pediatric Esophageal Atresia device through the Humanitarian Device Exemption (HDE) pathway.
Key facts
- Study ID
- NCT03615495
- Run by
- Cook Research Incorporated
- People needed
- 21
- Starts
- 2018-11-05
- Expected to finish
- 2023-11-27
- Last updated by the study team
- 2023-12-06
Who can join
Age: any, up to 1. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Hawaii — Honolulu, Hawaii, United States
- Rush University Medical Center — Chicago, Illinois, United States
- University of Chicago Medical Center — Chicago, Illinois, United States
- Boston Children's Hospital — Boston, Massachusetts, United States
- St. Louis Children's Hospital — St Louis, Missouri, United States
- Brenner Children's Hospital — Winston-Salem, North Carolina, United States
- Cincinnati Children's Hospital — Cincinnati, Ohio, United States
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
- Children's Medical Center — Dallas, Texas, United States
- Carilion Children's Hospital — Roanoke, Virginia, United States
- American Family Children's Hospital — Madison, Wisconsin, United States
- McGill University Department of Pediatric Surgery — Montreal, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.